Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Preclinical and Clinical Approaches to Mesothelioma, an Archetypal Inflammatory Tumor

NCT06536179 is registered in ClinicalTrials.gov with Marco Emilio Bianchi as lead sponsor.

NCT NCT06536179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06536179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Preclinical and Clinical Approaches to Mesothelioma, an Archetypal Inflammatory Tumor
Lead sponsor
Marco Emilio Bianchi
Phase
Observational
Overall status
Recruiting
Start date
July 25, 2024
Completion date
January 25, 2027
Enrollment
70 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

mesothelioma